0000880771-17-000106.txt : 20170614
0000880771-17-000106.hdr.sgml : 20170614
20170614164818
ACCESSION NUMBER: 0000880771-17-000106
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20170612
FILED AS OF DATE: 20170614
DATE AS OF CHANGE: 20170614
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: SCICLONE PHARMACEUTICALS INC
CENTRAL INDEX KEY: 0000880771
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 943116852
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 950 TOWER LANE
STREET 2: SUITE 900
CITY: FOSTER CITY
STATE: CA
ZIP: 94404-2125
BUSINESS PHONE: 650-358-3456
MAIL ADDRESS:
STREET 1: 950 TOWER LANE
STREET 2: SUITE 900
CITY: FOSTER CITY
STATE: CA
ZIP: 94404-2125
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Zhao Hong
CENTRAL INDEX KEY: 0001576318
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-19825
FILM NUMBER: 17911615
MAIL ADDRESS:
STREET 1: 30F SHANGHAI TIMES SQUARE, NO. 93
STREET 2: HUAI HAI ROAD
CITY: SHANGHAI
STATE: F4
ZIP: 200021
4
1
certent-form4.xml
PRIMARY DOCUMENT
X0306
4
2017-06-12
0000880771
SCICLONE PHARMACEUTICALS INC
SCLN
0001576318
Zhao Hong
950 TOWER LANE, SUITE 900
FOSTER CITY
CA
94404
0
1
0
0
CEO, China Operations
Common Stock
2017-06-12
4
M
0
12500
0
A
12500
D
Common Stock
2017-06-12
4
M
0
25000
0
A
37500
D
Common Stock
2017-06-12
4
M
0
3000
0
A
40500
D
Common Stock
2017-06-12
4
S
0
3000
10.75
D
37500
D
Common Stock
2017-06-12
4
S
0
12500
10.75
D
25000
D
Common Stock
2017-06-12
4
S
0
25000
10.75
D
0
D
Restricted Stock Unit
2017-06-12
4
M
0
12500
0
D
Common Stock
12500
185000
D
Restricted Stock Unit
2017-06-12
4
M
0
25000
0
D
Common Stock
25000
160000
D
Restricted Stock Unit
2017-06-12
4
M
0
3000
0
D
Common Stock
3000
157000
D
Granted under the Issuer's 2005 Equity Incentive Plan.
Each restricted stock unit represents the right to receive, at settlement, one share of common stock.
Provided Reporting Person remains employed by the Issuer, 25% of the restricted stock units will vest on each August 9, 2014, August 9, 2015, August 9, 2016, and August 9, 2017, unless the trading window is closed for the Reporting Person on such date, in which case the vesting date will be deferred until the next date that the trading window is open.
Provided Reporting Person remains employed by the Issuer, 33.33% of the restricted stock units vested on January 4, 2016, 33.33% will vest on January 3,2017, and 33.34% will vest on January 2, 2017, unless the trading window is closed for the Reporting Person on such date, in which case the vesting date will be deferred until the next date that the trading window is open.
Vesting for such RSUs will occur 25% on March 16, 2016, 25% on March 16, 2017, 25% on March 16, 2018, and 25% on March 16, 2019, or on such later date thereafter as the Company's trading window opens, if it is not open on any of such dates, contingent upon the executive's continued employment.
/s/ Wilson W. Cheung, Attorney-in-Fact For: Hong Zhao
2017-06-14